Abstract
BALB/c is a susceptible strain for the development of γ-ray induced mouse thymic lymphoma whereas MSM shows resistance. Association analysis of 220 backcross mice between the two strains using 67 markers was carried out to identify loci involved in the control of susceptibility. The genotype of mice with lymphoma showed excess heterozygosity relative to MSM homozygosity at D2Mit15 and D4Mit12 and was skewed toward MSM-derived alleles at D5Mit5. The P values in Mantel-Cox test were 0.0048 (D2Mit15), 0.0034 (D4Mit12) and 0.0048 (D5Mit5), suggesting association at the three loci in the susceptibility. Cooperative effect on lymphomagenesis was also observed among the three loci. To obtain independent evidence for linkage at D4Mit12, we made partially congenic mice in which a D4Mit12 region in BALB/c was replaced by MSM-derived homolog. Examination for the lymphoma susceptibility in 78 progeny of the congenic mice confirmed the effect of the locus near D4Mit12 (P=0.0037). The result, together with the linkage analysis, shows that the locus near D4Mit12 is regarded as a confirmed linkage but the other two loci as marginally suggestive.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Balmain A, Nagase H . 1998 Trends Genet. 14: 139–144
Baross-Francis A, Milhausen MK, Andrew SE, Jevon G, Jirik FR . 2000 Carcinogenesis 21: 1259–1262
Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF, Lander ES . 1997 Nature Genet. 17: 88–91
Darvasi A . 1998 Nature Genet. 18: 19–24
Demant P . 1992 Cancer Biol. 3: 159–166
Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W . 1993 Cell 75: 631–639
Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ, Evans CA, DeAngelis MM, Levinson DM, Kruglyak L, Goodman N, Copeland NG, Jenkins NA, Hawkins TL, Stein L, Page DC, Lander ES . 1996 Nature 380: 149–152
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A . 1992 Nature 356: 215–221
Giaccia AJ, Kastan MB . 1998 Genes. Dev. 12: 2973–2983
Kaplan HS, Brown MB . 1952 J. Natl. Cancer Inst. 13: 185–208
Lander E, Kruglyak L . 1995 Nature Genet. 11: 241–247
Liyanage M, Weaver Z, Barlow C, Coleman A, Pankratz DG, Anderson S, Wynshaw-Boris A, Ried T . 2000 Blood 96: 1940–1946
Macphee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM . 1995 Cell 81: 957–966
Markel P, Shu P, Ebeling C, Carlson GA, Nagle DL, Smutko JS, Moore KJ . 1997 Nature Genet. 17: 280–284
Matsumoto Y, Kosugi S, Shinbo T, Chou D, Ohashi M, Wakabayashi Y, Sakai K, Okumoto M, Mori N, Aizawa S, Niwa O, Kominami R . 1998 Oncogene 16: 2747–2754
Meruelo D, Offer M, Flieger N . 1981 J. Exp. Med. 154: 1201–1211
Moen CJA, Groot PC, Hart AAM, Snoek M, Demant P . 1996 Genetics 93: 1082–1086
Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A . 1995 Nature Genet. 10: 424–429
Okano H, Saito Y, Miyazawa T, Shinbo T, Chou D, Kosugi S, Takahashi Y, Odani S, Niwa O, Kominami R . 1999 Oncogene 18: 6677–6683
Okumoto M, Nishikawa R, Imai S, Hilgers J . 1990 Cancer Res. 50: 3848–3850
Perera FP . 1996 J. Natl. Cancer Inst. 88: 496–509
Ponder BAJ . 1990 Trends Genet. 6: 213–218
Shinbo T, Matsuki A, Matsumoto Y, Kosugi S, Takahashi Y, Niwa O, Kominami R . 1999 Oncogene 18: 4131–4136
Shisa H, Yamada Y, Kawarai A, Terada N, Kawai M, Matsushiro H, Hiai H . 1996 Jpn. J. Cancer Res. 87: 258–262
Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF . 1992 Science 256: 668–670
Sun L, Heerema N, Crotty L, Wu X, Christopher N, Vassilev A, Sensel M, Reaman GH, Uckun FM . 1999 Proc. Natl. Acad. Sci. USA 96: 680–685
Van Wezel T, Ruivenkamp CAL, Stassen APM, Moen CJA, Demant P . 1999 Cancer Res. 59: 4216–4218
Wang YA, Elson A, Leder P . 1997 Proc. Natl. Acad. Sci. USA 94: 14590–14595
Acknowledgements
We thank Dr Kouhei Akazawa for helpful discussion of statistical analysis. This work was supported by Health Sciences Research Grants from the Ministry of Health and Welfare of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saito, Y., Ochiai, Y., Kodama, Y. et al. Genetic loci controlling susceptibility to γ-ray-induced thymic lymphoma. Oncogene 20, 5243–5247 (2001). https://doi.org/10.1038/sj.onc.1204675
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204675
Keywords
This article is cited by
-
The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas
Oncogene (2010)
-
Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice
Oncogene (2005)
-
Predisposition to mouse thymic lymphomas in response to ionizing radiation depends on variant alleles encoding metal-responsive transcription factor-1 (Mtf-1)
Oncogene (2005)
-
Mapping of genetic modifiers of thymic lymphoma development in p53-knockout mice
Oncogene (2003)
-
A new locus for resistance to γ-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice
Oncogene (2002)
